Medtecs International Corporation Ltd DRC (TW:9103) — Stock Price
Medtecs International Corporation Ltd DRC (TW:9103) is currently trading at NT$5.28 TWD, up 0.00% today. Over the past 52 weeks, shares have ranged between NT$4.36 and NT$6.39. This page tracks Medtecs International Corporation Ltd DRC's live share price on the TW exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Medtecs International Corporation Ltd DR market cap and net worth.
Medtecs International Corporation Ltd DRC (9103) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Medtecs International Corporation Ltd DRC's daily closing share price and trading volume on the TW exchange over the past year, giving a clear view of recent price momentum and liquidity.
Medtecs International Corporation Ltd DRC Income Statement — Revenue, Profit & Earnings by Year
Medtecs International Corporation Ltd DRC's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | NT$78.39 Million | NT$54.42 Million | NT$52.64 Million | NT$56.24 Million | NT$144.16 Million |
| Cost of Revenue | NT$66.06 Million | NT$47.50 Million | NT$46.68 Million | NT$59.58 Million | NT$102.12 Million |
| Gross Profit | NT$12.33 Million | NT$6.92 Million | NT$5.96 Million | NT$-3.34 Million | NT$42.03 Million |
| Research & Development | — | — | — | — | — |
| SG&A | NT$16.83 Million | NT$29.32 Million | NT$23.31 Million | NT$17.72 Million | NT$13.85 Million |
| Total Operating Expenses | NT$18.97 Million | NT$31.10 Million | NT$30.95 Million | NT$29.73 Million | NT$25.32 Million |
| Operating Income | NT$-6.64 Million | NT$-24.18 Million | NT$-24.99 Million | NT$-33.07 Million | NT$16.01 Million |
| EBITDA | NT$-94.33K | NT$-15.26 Million | NT$-14.56 Million | NT$-23.43 Million | NT$24.37 Million |
| EBIT | NT$-6.64 Million | NT$-22.75 Million | NT$-21.77 Million | NT$-29.84 Million | NT$17.74 Million |
| Interest Expense | NT$805.29K | NT$764.00K | NT$742.00K | NT$819.00K | NT$853.00K |
| Income Before Tax | NT$-5.15 Million | NT$-23.52 Million | NT$-22.52 Million | NT$-30.65 Million | NT$16.92 Million |
| Income Tax Expense | NT$-354.49K | NT$135.00K | NT$-27.00K | NT$-1.39 Million | NT$408.00K |
| Net Income | NT$-4.80 Million | NT$-22.03 Million | NT$-21.07 Million | NT$-28.60 Million | NT$17.34 Million |
Medtecs International Corporation Ltd DRC Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Medtecs International Corporation Ltd DRC's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | NT$146.11 Million | NT$138.50 Million | NT$166.77 Million | NT$182.05 Million | NT$215.57 Million |
| Total Current Assets | NT$77.31 Million | NT$95.61 Million | NT$95.80 Million | NT$110.39 Million | NT$163.37 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | NT$3.87 Million | NT$10.55 Million | NT$5.36 Million | NT$17.16 Million | NT$9.28 Million |
| Net Receivables | NT$19.28 Million | NT$36.26 Million | NT$20.08 Million | NT$30.36 Million | NT$42.35 Million |
| Inventory | NT$28.26 Million | NT$25.07 Million | NT$37.36 Million | NT$36.39 Million | NT$49.66 Million |
| Property, Plant & Equipment | — | — | — | NT$60.50 Million | NT$44.95 Million |
| Goodwill | NT$709.00K | NT$709.00K | NT$709.00K | NT$709.00K | NT$709.00K |
| Total Liabilities | NT$44.00 Million | NT$31.44 Million | NT$36.46 Million | NT$29.73 Million | NT$27.67 Million |
| Total Current Liabilities | NT$39.94 Million | NT$27.89 Million | NT$32.97 Million | NT$25.08 Million | NT$20.63 Million |
| Long-term Debt | — | — | — | — | NT$0.00 |
| Net Debt | NT$6.24 Million | NT$5.53 Million | NT$4.60 Million | NT$1.43 Million | NT$-32.15 Million |
| Total Stockholder Equity | NT$101.62 Million | NT$106.57 Million | NT$129.20 Million | NT$149.79 Million | NT$185.21 Million |
| Retained Earnings | — | NT$77.20 Million | NT$99.62 Million | NT$120.42 Million | NT$152.29 Million |
Medtecs International Corporation Ltd DRC Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Medtecs International Corporation Ltd DRC generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | NT$-1.88 Million | NT$312.00K | NT$-7.18 Million | NT$-4.05 Million | NT$30.10 Million |
| Capital Expenditures | NT$3.71 Million | NT$2.76 Million | NT$7.41 Million | NT$19.78 Million | NT$16.37 Million |
| Free Cash Flow | NT$-5.59 Million | NT$-2.44 Million | NT$-14.59 Million | NT$-23.83 Million | NT$13.39 Million |
| Investing Cash Flow | NT$325.69K | NT$-398.00K | NT$9.61 Million | NT$-23.90 Million | NT$-15.42 Million |
| Financing Cash Flow | NT$269.09K | NT$-5.43 Million | NT$1.84 Million | NT$-2.96 Million | NT$-47.48 Million |
| Dividends Paid | — | — | — | NT$3.27 Million | NT$22.84 Million |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | NT$6.55 Million | NT$7.49 Million | NT$7.21 Million | NT$6.40 Million | NT$6.63 Million |
| Change in Cash | NT$-2.02 Million | NT$-5.51 Million | NT$4.18 Million | NT$-30.89 Million | NT$-33.15 Million |
Medtecs International Corporation Ltd DRC Earnings History — EPS Actual vs. Analyst Estimates
Track Medtecs International Corporation Ltd DRC's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Feb 25, 2026 | — | — | — |
| Aug 08, 2025 | — | — | — |
| Feb 27, 2025 | — | — | — |